Related Experiment Video
Updated: Jul 30, 2026

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells
Published on: June 30, 2023
Atg16L1 as a Novel Biomarker and Autophagy Gene for Diabetic Retinopathy
Xinxiao Gao1,2, Yunhui Du3, Wayne Bond Lau4
1Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China.
Objective:
Accumulating evidence suggests the critical role of autophagy in the pathogenesis of diabetic retinopathy (DR). In the current study, we aim to identify autophagy genes involved in DR via microarray analyses.
Methods:
Gene microarrays were performed to identify differentially expressed lncRNAs/mRNAs between normal and DR retinas. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analyses of lncRNA-coexpressed mRNAs were used to determine the related pathological pathways and biological modules. Real-time polymerase chain reactions (PCR) were conducted to validate the microarray analyses.
Results:
A total of 2474 significantly dysregulated lncRNAs and 959 differentially expressed mRNAs were identified in the retina of DR. Based upon Signalnet analysis, Bcl2, Gabarapl2, Atg4c, and Atg16L1 participated the process of cell death in DR. Moreover, real-time PCR revealed significant upregulation of Atg16L1.
Conclusion:
This study indicated the importance and potential role of Atg16L1, one of the autophagy genes, as a biomarker in DR development and progression.
More Related Videos
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Diabetic Retinopathy

